A recent report, proposing the function of cytoplasmic NIS as an element of a pathway involved in tumor cell invasive capacity[76], suggests a role of cytoplasmic NIS in tumor aggressiveness, strengthening the hypothesis of using NIS expression as biomarker for defining individuals with biologically active prostate cancer. The gene discussed is SLC5A5; the disease is Familial prostate cancer.